Following the finding that RCC-susceptibility GWAS signals overlap HIF-binding sites at intergenic enhancers of CCND1 and MYC [7,8], we undertook a systematic analysis of the overlap between published RCC GWAS signals and the HIF-transcriptional apparatus. This evidence concerns the gene CCND1 and renal cell adenocarcinoma.